降钙素原检测市场:各市场区隔规模，占有率，法律规章，偿付，2033年为止的预测

败血症是一种危及生命的疾病，其特征是患者对感染的异常反应导致器官功能障碍。降钙素原测试提供了一种区分细菌和病毒感染并监测抗生素治疗有效性的方法。然而，这些测试不仅用于败血症患者。降钙素原可用于监测下呼吸道感染 (LRTI)、细菌性肺炎或需要机械通气的患者的潜在感染。

降钙素原 (PCT) 测试透过测量 PCT（激素降钙素的胜?前体）的产生来诊断和监测败血症。 PCT 因发炎刺激而增加，通常是细菌感染的结果。

本报告提供全球降钙素原检测市场相关资料详细考察，提供市场上竞争情形，SWOT分析，到2033年为止的市场预测，地区，各国的趋势等资讯。

目录

已上市的降钙素原检测和不断变化的竞争格局

• 主要的产业趋势洞察
• 降钙素原检测的各市场区隔整体市场收益和2015年～2033年的市场展望
• 件数，平均销售价格，市场价值相关详细资料

世界，地区，各国洞察

• 降钙素原检测市场SWOT分析
• 降钙素原检测市场相关竞争动态的洞察和趋势
• 各国医疗制度概要
• 各国偿付政策
• 各国医疗技术相关法规状况

Procalcitonin Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area.

Sepsis is a life-threatening condition characterized by organ dysfunction caused by a patient's dysregulated response to infection. Procalcitonin testing provides a means for distinguishing bacterial from viral infection and monitoring the efficacy of antibiotic treatment. However, such tests are not used exclusively for sepsis patients. Procalcitonin may be used for patients with Lower Respiratory Tract Infections (LRTI), bacterial Pneumonia, or for monitoring potential infection of patients requiring mechanical ventilation.

Procalcitonin (PCT) Tests are carried out to diagnose and monitor sepsis, by measuring the production of PCT, a peptide precursor of the hormone calcitonin, which increases in response to a pro-inflammatory stimulus, typically as a result of bacterial infection.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Procalcitonin Test and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Procalcitonin Tests market revenue by segment and market outlooks from

2015- 2033.

• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Procalcitonin Tests market.
• Competitive dynamics insights and trends provided for Procalcitonin Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific MedTech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Thermo Fisher Scientific Inc, Beckman Coulter Inc + Radiometer Medical ApS, F. Hoffmann-La Roche Ltd, bioMerieux SA,Bio-Rad laboratories Inc, Siemens Healthineers AG, DiaSorin SpA, Quidel Corp and Diazyme Laboratories Inc and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Procalcitonin Tests market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Procalcitonin Tests market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Procalcitonin Tests market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Procalcitonin Tests market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.